Biotech stocks with the lowest EV/EBIT

Ranked

17

of 146 biotech stocks we cover

Median

18.2×

Lowest

4.6×

MGTX

Range

4.6× to 160×

#	Company	EV/EBIT	PE	Operating margin	Market cap
1	MGTXMeiraGTx	4.6×	13.0×	46.3%	$884.6M
2	PLXProtalix BioTherapeutics	7.5×	11.1×	28.9%	$205.5M
3	AGENAgenus	7.9×	n/m	27.3%	$285M
4	INCYIncyte	10.1×	14.7×	30.6%	$23.5B
5	ADMAAdma Biologics	10.9×	15.3×	43.8%	$2.4B
6	EXELExelixis	15.4×	20.3×	39.9%	$16B
7	UTHRUnited Therapeutics	16.1×	21.0×	44.4%	$25.2B
8	HALOHalozyme Therapeutics	17.4×	37.5×	35.9%	$14.3B
9	NBIXNeurocrine Biosciences	18.2×	20.9×	23.6%	$14.5B
10	REGNRegeneron Pharmaceuticals	20.0×	19.9×	24.7%	$82.9B
11	VRTXVertex Pharmaceuticals	26.6×	30.5×	38.0%	$132.8B
12	ALNYAlnylam Pharmaceuticals	27.9×	37.8×	20.8%	$30B
13	ONCBeOne Medicines	42.2×	67.6×	15.1%	$42.9B
14	KRYSKrystal Biotech	42.4×	39.0×	44.9%	$9.2B
15	TECHBIO-TECHNE	44.9×	63.1×	20.7%	$11.4B
16	VCELVericel	116×	92.5×	6.0%	$2.2B
17	RGENRepligen	160×	242×	8.2%	$10B

Not ranked: 115 with a loss over the last year, 3 with not a meaningful number. 11 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.